Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Mary Mosley
Authored Items
Intensive Treatment Early in Type 1 Diabetes Produces Substantial Long-Term Benefits
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Albiglutide, a GLP-1 Receptor Agonist, Effective in Various Treatment Scenarios in Patients with Type 2 Diabetes
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
in
Emerging Therapies
Costs of Diabetes-Related Complications Reduced with Canagliflozin Monotherapy
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Resource Utilization and Costs: Comparing Saxagliptin and Sitagliptin
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Substantial Costs for Diabetes Are Consumed by the Diabetic Foot and Arthritis
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Specialized Team Approach and Education Improve Care, Save Money in Diabetes
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Highlights from the ADA President’s Research Sessions
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Pooled Analysis Confirms CV Benefits of DPP-4 Inhibition
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Adding Linagliptin to Basal Insulin Reduces Hypoglycemia in Older Patients with Type 2 Diabetes
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Novel Predictors of Outcomes in Diabetes
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Reductions in HbA1c Levels, Hypoglycemia, and Weight with Linagliptin in Patients with Type 2 Diabetes and Renal Impairment
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Lifestyle Intervention Beneficial in Patients with Diabetes, but Not for CV Parameters
Mary Mosley
August 2013, Vol 6 ADA 2013 Highlights
Hypertension: Highlights from ESC 2012
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
Aspirin Safely Omitted from Antithrombotic Therapy in Patients with AF Undergoing PCI
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
New Prognostic Markers in Hypertension Identified
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
First-in-Class Angiotensin Receptor Neprilysin Inhibitor Promising in Heart Failure with Preserved Ejection Fraction
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
in
Emerging Therapies
RELAX-AHF: Serelaxin Reduces Dyspnea in Acute Heart Failure
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
in
Emerging Therapies
PHS II: Cardiovascular Events in Men Not Reduced with Multivitamins
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
in
Cardiometabolic Health
Third Definition of Myocardial Infarction Presented at ESC 2012, Focusing on New High-Sensitivity Biomarkers
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
in
Cardiometabolic Health
CVD Pipeline: Novel Approaches to Modifying Lipids/Lipoproteins
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
in
Emerging Therapies
Belly Fat Triples CV and All-Cause Mortality, Even with Normal Weight
Mary Mosley
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
Real-Time Continuous Glucose Monitoring Cost-Effective in Patients with Type 2 Diabetes
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Sustained Glycemic Control with Once-Weekly Exenatide Reduces Cardiometabolic Risk Factors
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
in
Cardiometabolic Health
UKPDS Follow-Up: Early HbA1c Reductions Linked to a Decrease in MI, All-Cause Mortality
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
in
Cardiometabolic Health
Medical Costs Increase as Chronic Kidney Disease Worsens
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
ORIGIN: Insulin Glargine and Omega-3 Do Not Improve Cardiovascular Outcomes in Patients with Type 2 Diabetes
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
in
Cardiometabolic Health
Real-Time Continuous Glucose Monitoring Cost-Effective in Patients with Type 2 Diabetes
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
Incretin Impairment: The Role of GLP-1 and DPP-4 in Type 2 Diabetes Management
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
Ninety Years of Insulin: What’s Needed? What’s New?
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
rHuPH20 Added to Rapid-Acting Insulin Noninferior to Lispro in Type 1 Diabetes
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
Novel Risk Factors for Type 2 Diabetes
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
Diabetic Retinopathy: Beneficial Effects Shown in Experimental Model with Linagliptin
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
TODAY Study: New Data, Implications for Young Patients with Diabetes
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
Empagliflozin Safe and Effective with or without Metformin, Reduces Weight
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
in
Emerging Therapies
Lixisenatide Continues to Show Good Results in GetGoal Program Studies
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
in
Emerging Therapies
Medical Spending for Diabetes, 1987-2008: Where Does the Money Go?
Mary Mosley
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
TODAY Study: New Data, Implications for Young Patients with Diabetes
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Novel Risk Factors for Type 2 Diabetes
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Empagliflozin Safe and Effective with or without Metformin, Reduces Weight
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
in
Emerging Therapies
Ninety Years of Insulin: What’s Needed? What’s New?
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Lixisenatide Continues to Show Good Results in GetGoal Program Studies
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
in
Emerging Therapies
Incretin Impairment: The Role of GLP-1 and DPP-4 in Type 2 Diabetes Management
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Medical Costs Increase as Chronic Kidney Disease Worsens
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Real-Time Continuous Glucose Monitoring Cost-Effective in Patients with Type 2 Diabetes
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
ORIGIN: Insulin Glargine and Omega-3 Do Not Improve Cardiovascular Outcomes in Patients with Type 2 Diabetes
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
in
Cardiometabolic Health
Sustained Glycemic Control with Once-Weekly Exenatide Reduces Cardiometabolic Risk Factors
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
in
Cardiometabolic Health
Diabetic Retinopathy: Beneficial Effects Shown in Experimental Model with Linagliptin
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
Medical Spending for Diabetes, 1987-2008: Where Does the Money Go?
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
rHuPH20 Added to Rapid-Acting Insulin Noninferior to Lispro in Type 1 Diabetes
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
UKPDS Follow-Up: Early HbA1c Reductions Linked to a Decrease in MI, All-Cause Mortality
Mary Mosley
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
in
Cardiometabolic Health
Value of Remote Disease Management of Arrhythmia Highlighted at ACC 2012
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
in
Cardiometabolic Health
Faster, Safer Discharge from Emergency Department with Coronary CT Angiography
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
in
Cardiometabolic Health
Vorapaxar, a Novel Antithrombotic Agent, Reduces Events but Increases Bleeding
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
in
Cardiometabolic Health
Comparative Effectiveness Analysis of Coronary Bypass Surgery and Percutaneous Revascularization
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
in
Cardiometabolic Health
Dabigatran Safe and Effective Anticoagulant Postablation in Patients with Atrial Fibrillation
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
Advances in Stem-Cell Therapy for Heart Failure
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
Comparative Effectiveness Analysis of Antithrombotics in Older Patients with Post-ACS Atrial Fibrillation
Mary Mosley
September/October 2011 Volume 4, Number 6
Comparative Effectiveness Analysis: Emergency Department CTA versus Standard ACS Symptom Evaluation
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
New JNC-8 Hypertension Guidelines to Be Released by Year End
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
ACC Launches Legends of Cardiovascular Medicine Series
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
in
Cardiometabolic Health
Value-Based Purchasing: Cardiologists Urged to Move from Quantity to Quality of Care
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
Coronary Computed Tomography Angiography Cost-Effective in CAD
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
Cost-Effective Imaging: What Parameters Determine Value?
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
Novel Oral Anticoagulants Reduce Total Medical Costs in Patients with Nonvalvular Atrial Fibrillation
Mary Mosley
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
Last modified: July 13, 2012